XML 97 R8.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Shareholders' Equity (Deficit) Statement - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2017   758.7       318.4  
Beginning balance at Dec. 31, 2017 $ (714.7) $ 189.7 $ 2,291.2 $ 2,320.3 $ (926.2) $ (4,600.0) $ 10.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (21.1)     (20.3)     (0.8)
Other comprehensive (loss) income 35.6       35.2   0.4
Dividends accrued - Series C convertible preferred stock (6.0)     (6.0)      
Exercise/ vesting/ expense of share-based compensation (in shares)   2.2       (0.1)  
Exercise/ vesting/ expense of share-based compensation 3.6 $ 0.6 2.5 (0.4)   $ 0.9  
Repurchase of common stock (in shares)           0.9  
Repurchase of common stock (2.7)         $ (2.7)  
Purchases and sales of noncontrolling interests, net of dividends paid (0.2)           (0.2)
Ending balance (in shares) at Mar. 31, 2018   760.9       319.2  
Ending balance at Mar. 31, 2018 (746.6) $ 190.3 2,293.7 2,252.5 (891.0) $ (4,601.8) 9.7
Beginning balance (in shares) at Dec. 31, 2017   758.7       318.4  
Beginning balance at Dec. 31, 2017 (714.7) $ 189.7 2,291.2 2,320.3 (926.2) $ (4,600.0) 10.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 55.7            
Other comprehensive (loss) income (90.0)            
Ending balance (in shares) at Sep. 30, 2018   761.7       319.4  
Ending balance at Sep. 30, 2018 (803.0) $ 190.3 2,299.1 2,318.3 (1,015.9) $ (4,602.3) 7.5
Beginning balance (in shares) at Mar. 31, 2018   760.9       319.2  
Beginning balance at Mar. 31, 2018 (746.6) $ 190.3 2,293.7 2,252.5 (891.0) $ (4,601.8) 9.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (37.0)     (36.1)     (0.9)
Other comprehensive (loss) income (123.8)       (123.4)   (0.4)
Dividends accrued - Series C convertible preferred stock (6.0)     (6.0)      
Exercise/ vesting/ expense of share-based compensation (in shares)   0.8          
Exercise/ vesting/ expense of share-based compensation 3.4   3.8 (0.4)      
Repurchase of common stock (in shares)           0.2  
Repurchase of common stock (0.5)         $ (0.5)  
Ending balance (in shares) at Jun. 30, 2018   761.7       319.4  
Ending balance at Jun. 30, 2018 (910.5) $ 190.3 2,297.5 2,210.0 (1,014.4) $ (4,602.3) 8.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 113.8     114.5     (0.7)
Other comprehensive (loss) income (1.7)       (1.5)   (0.2)
Dividends accrued - Series C convertible preferred stock (6.2)     (6.2)      
Exercise/ vesting/ expense of share-based compensation 1.6   1.6        
Ending balance (in shares) at Sep. 30, 2018   761.7       319.4  
Ending balance at Sep. 30, 2018 (803.0) $ 190.3 2,299.1 2,318.3 (1,015.9) $ (4,602.3) 7.5
Beginning balance (in shares) at Dec. 31, 2018   761.8       319.4  
Beginning balance at Dec. 31, 2018 (896.8) $ 190.3 2,303.6 2,234.3 (1,030.4) $ (4,602.3) 7.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (33.5)     (32.7)     (0.8)
Other comprehensive (loss) income (3.9)       (4.0)   0.1
Dividends accrued - Series C convertible preferred stock (6.2)     (6.2)      
Exercise/ vesting/ expense of share-based compensation (in shares)   1.3          
Exercise/ vesting/ expense of share-based compensation (1.2) $ 0.3 (1.5)        
Purchases and sales of noncontrolling interests, net of dividends paid 0.1           0.1
Ending balance (in shares) at Mar. 31, 2019   763.1       319.4  
Ending balance at Mar. 31, 2019 (941.5) $ 190.6 2,302.1 2,195.4 (1,034.4) $ (4,602.3) 7.1
Beginning balance (in shares) at Dec. 31, 2018   761.8       319.4  
Beginning balance at Dec. 31, 2018 (896.8) $ 190.3 2,303.6 2,234.3 (1,030.4) $ (4,602.3) 7.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 54.0            
Other comprehensive (loss) income (19.3)            
Ending balance (in shares) at Sep. 30, 2019   763.4       319.9  
Ending balance at Sep. 30, 2019 (875.2) $ 190.4 2,310.5 2,270.0 (1,049.7) $ (4,603.3) 6.9
Beginning balance (in shares) at Mar. 31, 2019   763.1       319.4  
Beginning balance at Mar. 31, 2019 (941.5) $ 190.6 2,302.1 2,195.4 (1,034.4) $ (4,602.3) 7.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (19.1)     (19.5)     0.4
Other comprehensive (loss) income 5.5       5.5   0.0
Dividends accrued - Series C convertible preferred stock (6.4)     (6.4)      
Exercise/ vesting/ expense of share-based compensation 5.4   5.4        
Repurchase of common stock (in shares)   0.1       0.5  
Repurchase of common stock (1.0) $ 0.1       $ (1.0)  
Purchases and sales of noncontrolling interests, net of dividends paid (0.3)           (0.3)
Ending balance (in shares) at Jun. 30, 2019   763.2       319.9  
Ending balance at Jun. 30, 2019 (957.3) $ 190.7 2,307.5 2,169.5 (1,028.9) $ (4,603.3) 7.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 106.6     106.9     (0.3)
Other comprehensive (loss) income (20.8)       (20.8)    
Dividends accrued - Series C convertible preferred stock (6.4)     (6.4)      
Exercise/ vesting/ expense of share-based compensation (in shares)   0.3          
Exercise/ vesting/ expense of share-based compensation 3.3 $ 0.3 3.0        
Repurchase of common stock (0.6) $ (0.6)          
Ending balance (in shares) at Sep. 30, 2019   763.4       319.9  
Ending balance at Sep. 30, 2019 $ (875.2) $ 190.4 $ 2,310.5 $ 2,270.0 $ (1,049.7) $ (4,603.3) $ 6.9